Insider Selling: Calyxt Inc (CLXT) Insider Sells 4,666 Shares of Stock

Calyxt Inc (NASDAQ:CLXT) insider Daniel F. Voytas sold 4,666 shares of the firm’s stock in a transaction on Wednesday, June 20th. The stock was sold at an average price of $20.56, for a total transaction of $95,932.96. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Daniel F. Voytas also recently made the following trade(s):

  • On Friday, June 15th, Daniel F. Voytas sold 7,539 shares of Calyxt stock. The stock was sold at an average price of $19.49, for a total transaction of $146,935.11.
  • On Monday, May 21st, Daniel F. Voytas sold 4,666 shares of Calyxt stock. The shares were sold at an average price of $16.63, for a total transaction of $77,595.58.
  • On Tuesday, May 8th, Daniel F. Voytas sold 4,083 shares of Calyxt stock. The shares were sold at an average price of $15.58, for a total transaction of $63,613.14.
  • On Friday, April 20th, Daniel F. Voytas sold 4,666 shares of Calyxt stock. The shares were sold at an average price of $16.87, for a total transaction of $78,715.42.
  • On Monday, April 9th, Daniel F. Voytas sold 4,083 shares of Calyxt stock. The shares were sold at an average price of $14.38, for a total transaction of $58,713.54.

Shares of NASDAQ:CLXT traded down $0.28 during midday trading on Friday, hitting $20.34. The stock had a trading volume of 638 shares, compared to its average volume of 125,426. The company has a market cap of $601.33 million and a price-to-earnings ratio of -18.09. The company has a quick ratio of 17.79, a current ratio of 17.79 and a debt-to-equity ratio of 0.27. Calyxt Inc has a 1 year low of $9.26 and a 1 year high of $31.89.

Calyxt (NASDAQ:CLXT) last issued its earnings results on Monday, May 7th. The company reported ($0.16) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.29) by $0.13. The business had revenue of $0.01 million for the quarter, compared to the consensus estimate of $0.20 million. Calyxt had a negative net margin of 5,930.60% and a negative return on equity of 60.81%. research analysts forecast that Calyxt Inc will post -1.14 EPS for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. acquired a new stake in shares of Calyxt in the fourth quarter valued at about $330,000. BlackRock Inc. lifted its stake in shares of Calyxt by 102.8% in the fourth quarter. BlackRock Inc. now owns 740,010 shares of the company’s stock valued at $16,302,000 after purchasing an additional 375,137 shares during the period. Deutsche Bank AG lifted its stake in shares of Calyxt by 151.3% in the fourth quarter. Deutsche Bank AG now owns 18,378 shares of the company’s stock valued at $404,000 after purchasing an additional 11,064 shares during the period. Finally, Wells Fargo & Company MN lifted its stake in shares of Calyxt by 1,421.9% in the fourth quarter. Wells Fargo & Company MN now owns 30,788 shares of the company’s stock valued at $678,000 after purchasing an additional 28,765 shares during the period. Hedge funds and other institutional investors own 21.78% of the company’s stock.

Several analysts have recently weighed in on CLXT shares. Jefferies Financial Group reaffirmed a “buy” rating and issued a $27.00 target price on shares of Calyxt in a report on Thursday, March 1st. Zacks Investment Research raised shares of Calyxt from a “hold” rating to a “buy” rating and set a $19.00 target price on the stock in a report on Monday, May 28th. Finally, ValuEngine raised shares of Calyxt from a “sell” rating to a “hold” rating in a report on Wednesday, March 14th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Calyxt currently has a consensus rating of “Buy” and a consensus price target of $27.38.

Calyxt Company Profile

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans.

Insider Buying and Selling by Quarter for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply